Selective potassium titanyl phosphate laser-assisted endoscopic dacryocystorhinostomy with cyanoacrylate flap fixation: A prospective comparative study Authors: Wei-Tsun Chen, Chia-Chi Lee, Wei-Ping Hsia, Li-Chen Wei Published: 2026 ABSTRACT Purpose:To compare intraoperative blood loss and surgical success between potassium titanyl phosphate (KTP) laser-assisted and conventional cold steel endoscopic dacryocystorhinostomy (enDCR).Methods:Design: Prospective, non randomized comparative interventional study. Setting: Single tertiary referral center. Patients: Adults with primary acquired nasolacrimal duct obstruction were prospectively enrolled between March 2023 and June 2024. Intervention: Patients were assigned to either KTP laser-assisted enDCR or cold steel enDCR, differing only in the method of nasal mucosal incision. In both groups, bone removal and lacrimal sac opening were performed with cold steel instruments, and mucosal flaps were secured using 2-octyl-cyanoacrylate adhesive. Main outcome measures: The primary outcome was surgical success at 9 months. Secondary outcomes included intraoperative blood loss and adhesive-related complications.Results:A total of 73 procedures were analyzed (cold steel: 36; KTP: 37). The KTP group demonstrated significantly lower median intraoperative blood loss compared to the cold steel group (0.05 g vs. 0.36 g; P < 0.001). Surgical success rates at 9 months were comparable between the two techniques (94.6% in the KTP group vs. 97.2% in the cold steel group; P = 1.000). No complications related to the cyanoacrylate adhesive were observed.Conclusions:Selective use of the KTP laser for mucosal incision, combined with cyanoacrylate flap fixation, significantly minimizes intraoperative bleeding while achieving high surgical success rates comparable to traditional cold steel enDCR. Primary acquired nasolacrimal duct obstruction (NLDO) is a prevalent cause of chronic epiphora. While external dacryocystorhinostomy (extDCR) remains the conventional gold standard with success rates ranging from 90% to 95%, it is associated with permanent facial scarring and potential disruption of the lacrimal pump mechanism.[1234] Endoscopic dacryocystorhinostomy (enDCR) has emerged as a comparable alternative, offering success rates of 81–96% while avoiding external incision.[2456] To further enhance surgical visualization and minimize intraoperative hemorrhage, laser-assisted enDCR was introduced; however, the reported success rates have been inconsistent, varying from 58% to 82%.[13457891011] This lower efficacy has been primarily attributed to the collateral thermal injury and subsequent fibrosis caused by laser application during osteotomy and lacrimal sac ablation.[14589] The motivation for this study stems from two frequent challenges in enDCR: Intraoperative bleeding, which compromises surgical visualization, and the technical difficulty of precise mucosal flap apposition. To address these issues, we implemented a refined selective approach—utilizing the potassium titanyl phosphate (KTP) laser exclusively for nasal mucosal incision to ensure a bloodless field, while employing conventional cold instruments for bone removal and sac opening to avoid thermal damage. Furthermore, we evaluated the use of 2-octyl-cyanoacrylate adhesive for flap stabilization, offering a cost-effective alternative to traditional fibrin glue. This prospective study aims to evaluate and compare intraoperative blood loss and surgical success rates between this selective KTP-assisted approach and conventional cold steel enDCR. Methods Study design and participants This was a prospective, nonrandomized comparative study performed at a single tertiary referral center in Taiwan between March 2023 and June 2024. Inclusion criteria were adults (≥18 years) diagnosed with primary acquired NLDO who presented with symptomatic epiphora, with or without mucocele or a history of dacryocystitis. Exclusion criteria included congenital NLDO, canalicular or punctal obstruction, immunodeficiency, or significant nasal deformity. Only patients who completed the 9-month follow-up were included. Preoperative evaluation involved a complete ophthalmologic examination and lacrimal irrigation to confirm NLDO. Nasal endoscopy was performed to exclude obstructive lesions. Radiographic imaging was not routinely performed. Preoperative laboratory values—including hemoglobin, platelet count, prothrombin time, and activated partial thromboplastin time (aPTT)—were documented. This study adhered to the tenets of the Declaration of Helsinki, with approval from the institutional review board (IRB No. CF23256C). Informed written consent was obtained from all patients. Surgical technique All procedures were performed by a single surgeon under general anesthesia. The nasal mucosa was first decongested with a nasal pack soaked in 2% lidocaine with 1:200,000 adrenaline for 5 minutes. A 3-mm 0-degree rigid nasal endoscope was then inserted, and the middle turbinate was gently reflected medially to expose the lacrimal bone. Submucosal injection of 2% lidocaine with 1:200,000 adrenaline was administered along the maxillary line. Patients were assigned to either the KTP laser group or the cold steel group for mucosal incision. In the KTP group, a 10–12 mm incision was created using a 532-nm KTP laser (IDAS Laser System, WaveLight Aesthetic GmbH, Erlangen, Germany) with a 0.6-mm fiber at 6 W in continuous mode [Fig. 1, Video Clip 1]. In the cold steel group, a 2.2-mm angled slit knife was used. Immediately after the incision, a dry nasal pack was placed at the site to absorb blood for 30 s, then removed and weighed. The difference in nasal pack weight before and after use was recorded to the second decimal place. In both groups, the lacrimal bone was subsequently removed using a 2-mm Kerrison rongeur. The lacrimal sac was tented with a Bowman probe and incised vertically using a Wullstein sickle knife, followed by placement of a bicanalicular silicone stent. The posterior lacrimal sac flap was reflected and apposed to the lateral nasal mucosa. To promote adhesion, a single drop of 2-octyl-cyanoacrylate adhesive (TissueAid, GeneJet Biotech, New Taipei City, Taiwan) was applied between the flap surfaces using a lumbar puncture needle attached to a 1-mL syringe [Fig. 2], taking care not to exceed one drop to avoid excessive spread or obstruction. Afterward, a nasal packing was left in place for 4 hours. Intraoperative view of nasal mucosal incision using the KTP laser: (a) Before laser application and (b) immediately after mucosal incision. KTP = potassium titanyl phosphate Apposition of the nasal mucosal flap and posterior lacrimal sac flap using 2-octyl-cyanoacrylate adhesive. The arrow indicates the site of adhesive application. (a) Before glue application and (b) after flap fixation Postoperative care and follow-up The postoperative medication regimen was standardized for all patients. Systematic treatment included oral cefadroxil (500 mg, every 12 hours) and oral tranexamic acid (TXA; 250 mg, three times daily) for 3 days. Topical therapy, administered for 1 week, consisted of 0.25% chloramphenicol eye drops (four times daily), 0.1% betamethasone eye drops (four times daily), and 0.3% gentamicin ophthalmic ointment (once nightly). Follow-up examinations were performed on postoperative day 2, at 1 month, and every 3 months thereafter. The silicone stent was left in place for 3 months and then removed at 3 months postoperatively, unless earlier removal was indicated by patient discomfort or clinical necessity. Outcome definitions Surgical success was defined as complete or partial resolution of symptoms without need for additional lacrimal surgery during the 9-month follow-up. Failure included persistent epiphora, ostium restenosis, abscess formation, or tube dislodgement accompanied by recurrent obstruction. Statistical analysis Statistical analysis was performed using SPSS version 22.0 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as median (interquartile range, IQR), and categorical variables as number (percentage). Eye-specific variables (laterality, indication, ocular history, preoperative blood pressure, and laboratory parameters related to intraoperative blood loss) were analyzed per procedure, whereas age, gender, and systemic disease were analyzed per patient. Group comparisons were conducted using Mann–Whitney U tests for continuous data and Chi-square or Fisher’s exact tests for categorical data. A two-tailed P value of <0.05 was considered statistically significant. Results A total of 73 enDCR procedures performed between March 2023 and June 2024 were included in this comparative analysis, comprising 36 procedures using the cold steel technique and 37 procedures using the KTP laser-assisted technique for nasal mucosal incision. No significant differences were found between the two groups in terms of gender, age, laterality, or ocular disease history. However, the KTP group had a significantly higher proportion of patients with diabetes mellitus (P = 0.044), while the cold steel group showed a higher prevalence of sinusitis history (P = 0.025). The detailed demographic and clinical characteristics are summarized in Table 1. Table 1Baseline characteristics in the KTP and cold steel groupsKTP (n=37)Cold steel (n=36) P Female27 (79.4%)33 (91.7%)0.182Age at surgery66.5 (50.0–75.3)59.5 (45.0–73.3)0.507Indication0.160 Primary epiphora28 (75.7%)33 (91.7%) Epiphora with mucocele8 (21.6%)3 (8.3%) Epiphora with prior dacryocystitis1 (2.7%)0 (0.0%)Comorbidities Hypertension10 (29.4%)9 (25.0%)0.678 Diabetes9 (26.5%)3 (8.3%)0.044* Dyslipidemia2 (5.9%)6 (16.7%)0.261 Coronary artery disease1 (2.9%)0 (0.0%)0.486 Gout1 (2.9%)3 (8.3%)0.615 Nonsurgical interventions for NLDO9 (24.3%)6 (16.7%)0.418 Pseudophakia9 (24.3%)9 (25.0%)0.947 Glaucoma2 (5.4%)3 (8.3%)0.674 Retinal disease1 (2.7%)6 (16.7%)0.056 Bilateral NLDO7 (18.9%)3 (8.3%)0.308 Previous nose surgery1 (2.9%)3 (8.3%)0.615 Chronic sinusitis0 (0.0%)6 (16.7%)0.025*Chi-square test/Fisher’s exact test or Mann–Whitney U test. Median (IQR) *P<0.05, **P <0.01. IQR=interquartile range, KTP=potassium titanyl phosphate, NLDO=nasolacrimal duct obstruction Baseline characteristics in the KTP and cold steel groups Chi-square test/Fisher’s exact test or Mann–Whitney U test. Median (IQR) *P<0.05, **P <0.01. IQR=interquartile range, KTP=potassium titanyl phosphate, NLDO=nasolacrimal duct obstruction The median intraoperative blood loss was 0.36 g (IQR: 0.07–0.49) in the cold steel group and 0.05 g (IQR: 0.02–0.12) in the KTP laser group, indicating significantly reduced intraoperative bleeding in the KTP laser-assisted procedures (P < 0.001). Preoperative laboratory parameters were generally comparable between groups, except for aPTT, which was significantly prolonged in the laser group (P = 0.009). A detailed comparison of intraoperative bleeding and laboratory findings is presented in Table 2. Table 2Intraoperative blood loss and preoperative laboratory parameters in the cold steel versus KTP laser groupsKTPCold steel P Eye number3736Patients3436Blood loss (g)0.05 (0.02–0.12)0.36 (0.07–0.49)<0.001**pre-op SBP (mmHg)131.00 (115.00–147.00)141.50 (119.00–148.50)0.282pre-op DBP (mmHg)75.00 (65.00–84.00)69.50 (65.25–79.75)0.249pre-op Plt (×109/L)247.00 (219.00–312.50)253.00 (228.50–322.75)0.856pre-op PT (sec)10.20 (10.05–10.30)10.20 (10.00–10.40)0.706pre-op aPTT (sec)28.50 (27.35–29.60)26.65 (26.43–28.90)0.009**pre-op INR0.98 (0.96–1.01)0.99 (0.97–1.02)0.180Mann–Whitney U test. Median (IQR) *P<0.05, **P<0.01. aPTT=activated partial thromboplastin time, DBP=diastolic blood pressure, INR=international normalized ratio, IQR=interquartile range, KTP=potassium titanyl phosphate, Plt=platelet, PT=prothrombin time, SBP=systolic blood pressure Intraoperative blood loss and preoperative laboratory parameters in the cold steel versus KTP laser groups Mann–Whitney U test. Median (IQR) *P<0.05, **P<0.01. aPTT=activated partial thromboplastin time, DBP=diastolic blood pressure, INR=international normalized ratio, IQR=interquartile range, KTP=potassium titanyl phosphate, Plt=platelet, PT=prothrombin time, SBP=systolic blood pressure At the 9-month postoperative follow-up, the overall surgical success rate was 97.2% (35/36) in the cold steel group and 94.6% (35/37) in the KTP laser group, with no statistically significant difference between the two techniques (P = 1.000). A total of three failures were identified—one in the cold steel group and two in the KTP laser group—all of which were attributed to cicatricial restenosis of the ostium secondary to excessive granulation tissue. No major postoperative complications, such as delayed hemorrhage, infection, or tissue necrosis, were observed in either cohort. Notably, all three failed cases were successfully managed via secondary revision enDCR, with all patients achieving complete symptomatic relief and maintaining ostium patency thereafter. Discussion The current study demonstrates that KTP laser-assisted enDCR, when selectively applied to the nasal mucosa in conjunction with cold steel osteotomy, achieves surgical success rates comparable to those of both extDCR and conventional enDCR. Furthermore, intraoperative blood loss was significantly lower in the KTP group, confirming that precise laser-mediated mucosal incision provides superior hemostasis and enhances surgical visualization, thereby facilitating safer dissection. Additionally, the adjunctive use of 2-octyl-cyanoacrylate for flap fixation ensured stable approximation of mucosal flaps without postoperative complications, representing a practical and cost-effective advancement in lacrimal surgery compared to traditional fibrin glue. While extDCR remains the gold standard treatment for primary NLDO with success rates of 90–95%,[1234] enDCR has gained widespread acceptance due to its high efficacy, superior cosmesis without skin incisions, and preservation of the lacrimal pump mechanism. Nonetheless, laser-assisted enDCR has historically faced challenges in achieving mainstream adoption, as early studies reported considerably lower success rates (58–82%) that varied by laser type and technique.[13457891011] For instance, Holmium:YAG laser, while effective for osteotomy, generates substantial collateral thermal injury that increases the risk of ostium fibrosis and closure.[12] In contrast, the KTP laser, characterized by its 532 nm wavelength, is highly selective for hemoglobin, allowing for precise tissue vaporization with simultaneous hemostasis.[13] This unique photothermal profile ensures sharp incision margins while minimizing collateral thermal damage to adjacent soft tissues.[14] Beyond its specific wavelength properties, the KTP laser offers superior soft-tissue control through versatile photothermal effects that are modulated by the working distance: Direct contact facilitates precise incision, near-contact application allows for vaporization, and distance application ensures effective coagulation.[1516] Furthermore, the KTP system utilizes a lightweight, flexible fiber-delivery handpiece, which significantly enhances surgical maneuverability within the narrow and anatomically complex nasal cavity. Our technique diverges from prior laser-assisted methodologies by utilizing the KTP laser exclusively for the nasal mucosal incision, while performing the osteotomy and lacrimal sac opening with cold steel instruments. This hybrid approach preserves a wide and stable osteotomy while capitalizing on the hemostatic advantages of the KTP laser during the most vascular phase of the surgery. The significant reduction in intraoperative blood loss observed in the present study confirms that selective laser application enhances surgical visualization and facilitates safer dissection. Furthermore, postoperative adhesion is identified as the chief mechanism of failure.[1217] By restricting laser use to the nasal mucosa and avoiding thermal application to the bone and lacrimal sac tissue, we minimized the risk of thermal-induced fibrosis and synechiae, thereby ensuring long-term patency. To complement the intraoperative hemostatic effects of the KTP laser, we implemented a standardized perioperative protocol involving oral TXA. Maintaining a bloodless field is critical not only for surgical visualization but also for patient safety. Effective hemostasis in dacryocystorhinostomy prevents posterior blood drainage into the nasopharynx, which can cause gagging or potential airway obstruction—a particularly vital consideration in cases where procedures are performed under local anesthesia without endotracheal tube protection.[18] The role of TXA in DCR remains a subject of ongoing investigation. While we acknowledge that the current high-level evidence, including recent randomized controlled trials[19] and meta-analyses,[20] predominantly evaluates the efficacy of pre-operative TXA for reducing intraoperative hemorrhage, we extrapolated this rationale to the post-operative phase of our study. Our decision to prescribe a 3-day course of post-operative oral TXA was specifically aimed at addressing the inherent limitations of a selective laser approach. While the KTP laser provides excellent control during the highly vascular nasal mucosal phase, which serves as the primary source of intraoperative hemorrhage, the subsequent cold steel osteotomy and lacrimal sac incision are performed without laser-mediated hemostasis. Although these steps involve relatively less vascularity, they remain susceptible to persistent, low-grade oozing. We contend that such minor postoperative bleeding is not merely a logistical concern; residual blood within the surgical site can trigger a localized inflammatory response and promote excessive granulation tissue, both of which are recognized drivers of ostium restenosis. By suppressing this delayed oozing, we aimed to maintain a quiescent environment for optimal mucosal healing, thereby ensuring the long-term anatomical and functional success of the surgical ostium. Although cyanoacrylate tissue adhesives are well-established for cutaneous closure, they have been increasingly adapted for mucosal surfaces across various surgical specialties.[212223242526] Early formulations utilizing short-chain cyanoacrylates (methyl- or ethyl-derivatives) were associated with significant tissue irritation and inflammatory responses. In contrast, modern long-chain derivatives, such as the 2-octyl-cyanoacrylate used in our study, exhibit significantly reduced toxicity and improved biocompatibility.[232427] While fibrin glue remains the traditional preference for conjunctival or mucosal stabilization,[2528] long-chain cyanoacrylates have demonstrated efficacy in sealing small corneal perforations and glaucoma drainage device leaks.[282930] Characterized by rapid polymerization, robust adhesive strength, and superior cost-effectiveness, these modern adhesives also possess antimicrobial properties and hemostatic effects, making them particularly suitable for the bacteria-prone environment of the nasal mucosa. However, clinical reports on adhesive application in lacrimal surgery remain sparse,[3132] and to our knowledge, this is the first prospective series to evaluate the efficacy of 2-octyl-cyanoacrylate specifically in enDCR. Compared to fibrin sealants, cyanoacrylate offers several practical advantages. It typically polymerizes within 30–60 s,[33] whereas fibrin glue requires a minimum of 2 minutes for setting and necessitates a time-consuming thawing process,[34] which precludes its use in rapid surgical workflows. Furthermore, the economic burden of fibrin glue is approximately six times higher per patient. Given that flap stabilization is a critical determinant of surgical success in enDCR, the adjunctive use of 2-octyl-cyanoacrylate facilitates rapid and secure flap approximation. This effective closure approach not only optimizes operative efficiency but also contributes to long-term ostium stability, as evidenced by the high patency rates observed in our cohort. Analysis of the surgical failures in our cohort revealed that all three cases were attributed to cicatricial restenosis secondary to excessive granulation tissue. Notably, these failures were successfully managed by subsequent revision surgery, suggesting that early identification and timely re-intervention can effectively salvage initial failures in appropriately selected patients. To mitigate the risk of such closures and ensure long-term patency, our protocol utilized bicanalicular silicone intubation for a duration of 3 months. We acknowledge that recent high-level evidence suggests that routine stent insertion may not significantly improve success rates in primary enDCR for uncomplicated cases.[353637] Furthermore, longitudinal data indicate that prolonged intubation might potentially elevate the risk of late-onset re-stenosis.[38] However, bicanalicular intubation has been shown to be significantly beneficial in cases with suboptimal local conditions, such as small lacrimal sacs or chronic inflammatory pathologies, where it facilitates superior outcomes compared to non-stented cohorts.[3940] This aligns with our clinical rationale: Utilizing the stent as a temporary scaffold during the critical early healing phase to maintain anatomical patency in challenging or inflamed environments where early contraction is more likely. In the current study, we observed no stent-related complications, such as biofilm-associated infection, within the 3-month intubation period. These findings reinforce that a 3-month duration provides a reliable balance between maintaining ostium patency and minimizing stent-induced tissue morbidity. Despite its prospective comparative design, this study has several limitations that warrant consideration. First, the single-center nature and non-randomized assignment may limit the generalizability of the findings. Second, the relatively small number of failure events restricted our ability to perform a robust multivariate analysis of risk factors within the prospective cohort. Third, while a 9-month follow-up is generally sufficient to assess primary surgical outcomes in enDCR, it may not capture late-onset restenosis occurring beyond this period. Future multi-center studies with larger sample sizes, randomized designs, and extended follow-up durations are necessary to further validate these results. Conclusion In conclusion, our findings demonstrate that selective KTP laser application confined to the nasal mucosa, combined with cold steel osteotomy and cyanoacrylate-assisted flap stabilization, significantly reduces intraoperative hemorrhage and enhances surgical visualization without compromising success rates. This hybrid approach represents a safe, efficient, and cost-effective advancement in endoscopic lacrimal surgery, achieving high long-term patency comparable to conventional cold steel techniques. By optimizing surgical workflow and reducing material costs, this refined technique offers a practical alternative, particularly suitable for modern healthcare settings where balancing clinical excellence with cost containment is essential. Conflicts of interest There are no conflicts of interest. Video available on: https://www.ovid.com/jnls/ijo